
    
      Women where allocated to an oral combined contraceptive pill, or placebo or a LNG-IUS or a
      etonogestrel-releasing subdermal contraceptive implant at day 42 after delivery. After the
      provision of the contraceptive method a 0.5 mg/kg of deuterium 99.99% according to the weight
      of the mother will be administer to all women. One sample of saliva from the mother and the
      child will be collected every day until 21 days after enrollment. Additionally, weight,
      height and size of the leg of each child will be measured at baseline, at the day 11 and at
      the day 21 after enrollment. Also, a diary with information of change of diapers and number
      of breastfeeding will be kept by each mother.
    
  